#NATA webinar | #WorldThrombosisDay
13 October - 18:00 CEST
Heparin-induced thrombocytopenia (HIT)
JerroldLevy: Anticoagulation in suspected HIT in the ICU
Corinne Frère: HIT and cardiac surgery with cardiopulmonary bypass
@natapbm.bsky.social
@natapbm.bsky.social#NATA webinar | #WorldThrombosisDay
13 October - 18:00 CEST
Heparin-induced thrombocytopenia (HIT)
JerroldLevy: Anticoagulation in suspected HIT in the ICU
Corinne Frère: HIT and cardiac surgery with cardiopulmonary bypass
@thrombosiscan.bsky.socialRegular registration closes Oct. 14.
Make your plans before Thanksgiving.
Nov. 7 | Montréal + on demand afterward
thrombosiscanada.ca/2026Conference
@andreamariggio.bsky.social
@thjournal.bsky.social📌 Expert Consensus on Inferior Vena Cava Thrombosis
Read our interview with Marco Marietta discussing management of inferior vena cava thrombosis.
🔗 Read the article here: www.thieme-connect.de/products/ejo...
@thrombosiscan.bsky.socialSame patient. Same day. Two different answers.
Dr Grégoire Le Gal previews one of the real-world diagnostic challenges he’ll tackle at Thrombosis Unpacked: Decisions That Matter.
November 7 | Montréal or on demand afterward
@medchemexpress.bsky.social🩸Where do activated platelets go after a blood clot forms?
A new Science study points to the spleen, which can capture and clear highly activated platelets.
Could this reveal a new angle on thrombosis?
@thrombosiscan.bsky.socialWhat’s changing in pulmonary embolism care?
Conference Co-chair Dr Ben Lai previews why the new PE guidance matters.
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
@thrombosiscan.bsky.socialCome for the clinical questions. Stay for the conversations.
Learn. Discuss. Connect.
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
@sigtrans-sttt.bsky.socialThis review maps platelet signaling from hemostasis and #TissueRepair to immune regulation and disease, highlighting how dysregulated platelet activity contributes to #Thrombosis, #Cancer metastasis and #ChronicInflammation.
@thrombosiscan.bsky.socialHow should renal function influence anticoagulant choice? Thomas Mavrakanas tackles Apixaban in CKD and ESRD at this year’s Rapid Fire session.
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
@thrombosiscan.bsky.social“We’re going to have to think very differently about this than we have with traditional antithrombotics.” Hear Dr. Sharma discuss OCEANIC-STROKE with Dr. Maha Othman and Dr. Jameel Abdulrehman on CLOT Conversations. thrombosiscanada.ca/hcp/clot-con...
@apssupportuk.bsky.socialDutch cohort: among 140 CTEPH/CTEPD patients with aPL results, 9 (6%) met #APS criteria; 67% had recurrent VTE and 44% were triple-positive. Consistent with guideline-recommended APS screening in CTEPH; numbers were small: pubmed.ncbi.nlm.nih.gov/42712874/ #thrombosis
@hemehub.bsky.social🩸 HemeHub is honored to have Adam Cuker, MD, MS, on our Scientific Advisory Board.
A leader in hematology, Dr. Cuker brings expertise in hemophilia, thrombosis, and blood disorders to help advance HemeHub’s mission.
#HemeHub #Hematology #Hemophilia #Thrombosis #BloodDisorders
@liversmdpi.bsky.social📢 Editor's Choice
📌Review in #LiversMDPI
🧬 Mihăilă et al. review #liver and vascular involvement in Philadelphia-negative chronic #myeloproliferative neoplasms
🩺 #MPNs are linked to increased thrombotic risk, particularly splanchnic #thrombosis
📖 More here: brnw.ch/21x5yxt
@toppnews.bsky.social